NCT00928200: Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) |
|
|
| Terminated | 1 | 1 | US | Erwinase, Asparaginase, Elspar, Kidrolase, L-Asparaginase, Erwinia L-Asparaginase, Vincristine, Oncovin, Vincasar Pfs, Vincristine Sulfate, LCR, VCR, Dexamethasone, Decadron, Dexasone, Diodex, Hexadrol, Maxidex, Dexamethasone sodium phosphate, Dexamethasone acetate, Doxorubicin, Adriamycin, Rubex, Cytarabine, Cytosar-U, Ara-C, Arabinosylcytosine, Methotrexate, Otrexup, Rasuvo, Rheumatrex, Trexall, Amethopterin, Methotrexate Sodium, MTX, Triple Intrathecal Therapy, Dexrazoxane, Zinecard | Therapeutic Advances in Childhood Leukemia Consortium | Relapsed Acute Lymphoblastic Leukemia, Allergy to PEG e.Coli Asparaginase, Allergy to Native e.Coli Asparaginase | 06/10 | 06/10 | | |
NCT01403415: Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma |
|
|
| Completed | 1 | 13 | US, Canada | Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Fluorodelta, Fortecortin, Gammacorten, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, Visumetazone, Laboratory Biomarker Analysis, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Mitoxantrone Hydrochloride, CL 232315, DHAD, DHAQ, Dihydroxyanthracenedione Dihydrochloride, Mitoxantrone Dihydrochloride, Mitoxantroni Hydrochloridum, Mitozantrone Hydrochloride, Mitroxone, Neotalem, Novantrone, Onkotrone, Pralifan, Pegaspargase, L-Asparaginase with Polyethylene Glycol, Oncaspar, PEG-Asparaginase, PEG-L-Asparaginase, PEG-L-Asparaginase (Enzon - Kyowa Hakko), PEGLA, Polyethylene Glycol L-Asparaginase, Polyethylene Glycol-L-Asparaginase, Pharmacological Study, Temsirolimus, CCI-779, CCI-779 Rapamycin Analog, Cell Cycle Inhibitor 779, Rapamycin Analog, Rapamycin Analog CCI-779, Torisel, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate | National Cancer Institute (NCI) | Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma | 05/15 | | | |
NCT01324180: Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) |
|
|
| Completed | 1 | 14 | US | Metformin, Vincristine, Oncovin®, VCR, LCR, NSC #67574, Dexamethasone, Decadron®, Hexadrol®, Dexone®, Dexameth®, NSC #34521 (112004), PEG-asparaginase, Oncaspar, NSC #644954, Pegaspargase, Oncaspar®, Polyethylene, Glycol Conjugated L-asparaginase-H, Doxorubicin, Adriamycin®, NSC #123127 (102004), Intrathecal chemotherapy, Cytosine Arabinoside, Ara-C, Cytosar®, NSC #63878 (102004) | H. Lee Moffitt Cancer Center and Research Institute, Pediatric Cancer Foundation | Acute Lymphoblastic Leukemia | 11/16 | 07/17 | | |
